MS Speaks

Here is the abstract of the report mentioned in the article cited in the previous post.


AAN abstract (2020--exact date not given), "Progressive multifocal leukoencephalopathy in a patient on ocrelizumab monotherapy":



https://index.mirasmart.com/AAN2020/PDFfiles/AAN2020-004875.html


The last sentence of the Conclusions section might be worth noting:

This case emphasizes the importance of a thorough discussion of the risks and benefits of ocrelizumab, especially in patients at higher risk for infections, such as the elderly.